Top

Published in:

01-12-2012

What Promotes Cervical Cancer Screening Among Chamorro Women in California?

Authors: Sora P. Tanjasiri, Michele Mouttapa, Lola Sablan-Santos, Lourdes F. Quitugua

Published in: Journal of Cancer Education | Issue 4/2012

Abstract

Pacific Islander women represent a significant at-risk population for cervical cancer, yet little is known about the modifiable factors associated with routine Pap testing. Therefore, the aims of this paper are to report and discuss the known and unknown factors associated with cervical cancer screening among Chamorro women in California. This cross-sectional study explored the factors associated with receipt of regular Pap testing among Chamorro women age 18 years and older in California. A self-administered survey was designed and distributed to women in order to understand their knowledge, beliefs and behaviors regarding routine receipt of Pap tests. Only about two-thirds of women had received a Pap test within the past 2 years, which is below the U.S. average of 72 %. Significant predictors included younger age, health insurance coverage, knowledge of screening frequency, and medically correct beliefs regarding risk groups. These factors, however, accounted for less than 16 % of the variance in Pap testing behavior. We discuss the poor predictive value of existing demographic and theoretical variables, and discuss potentially new areas of research that can aid in the development of future intervention studies. Study limitations and implications are also discussed.

Miller BA, Chu KC, Hankey BF, Ries LAG (2007) Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control 19:227–256PubMedCrossRef

Kagawa-Singer M, Park Tanjasiri S, Lee SW, Foo MA, Ngoc Nguyen TU, Tran JH et al (2006) Breast and cervical cancer control among Pacific Islander and Southeast Asian Women: participatory action research strategies for baseline data collection in California. J Cancer Educ 21(1 Suppl):S53–S60PubMedCrossRef

Mishra SI, Luce-Aoelua PH, Hubbell FA (2001) Predictors of papanicolaou smear use among American Samoan women. J Gen Intern Med 16(5):320–324PubMedCrossRef

APALC (2005) The diverse face of Asians and Pacific Islanders in California. Asian Pacific American Legal Center, Los Angeles

Haddock RL, Whippy HJ, Talon RJ, Montano MV (2009) Ethnic disparities in cancer incidence among residents of Guam. Asian Pac J Cancer Prev 10(1):57–62PubMed

Minkler MM, Wallerstein N (2003) Community-based participatory research for health. John Wiley & Sons, San Francisco

Tanjasiri SP, Kagawa Singer ML, Nguyen T-UN, Foo MA (2002) Collaborative research as an essential component for addressing cancer disparities among Southeast Asian and Pacific Islander women. Heal Promot Pract 3(2):144–154CrossRef

Tanjasiri SP, Sablan-Santos L, Merrill V, Quitugua LF, Kuratani DG (2008) Promoting breast cancer screening among Chamorro women in Southern California. J Cancer Educ 23(1):10–17PubMedCrossRef

CDC. (2000). National Health Interview Survey: Cancer Control Module 2000, from Centers for Disease Control and Prevention. Available from http://www.cdc.gov/nchs/about/major/nhis/quest_data_related_1997_forward.htm

10.

UCLA. (2001). California Health Interview Survey: Adult Questionnaire 2001, from UCLA Center for Health Policy Research. Available at: http://www.chis.ucla.edu/pdf/CHIS2001_adult_q.pdf

11.

American Cancer Society (2009) Cancer prevention & early detection facts & figures. Atlanta, GA: American Cancer Society

12.

Kagawa-Singer M, Pourat N, Breen N, Coughlin S, McLean TA, McNeel TS et al (2007) Breast and cervical cancer screening rates of subgroups of Asian American women in California. Med Care Res Rev 64(6):706–730PubMedCrossRef

13.

Maxwell AE, Bastani R, Warda US (2000) Demographic predictors of cancer screening among Filipino and Korean immigrants in the United States. Am J Prev Med 18(1):62–68PubMedCrossRef

14.

Nagelkerke NJD (1991) A note on a general definition of the coefficient of determination. Biometrika 78(3):691–692

15.

Sirovich BE, Welch HG (2004) The frequency of Pap smear screening in the United States. J Gen Intern Med 19(3):243–250PubMedCrossRef

16.

Islam N, Kwon SC, Senie R, Kathuria N (2006) Breast and cervical cancer screening among South Asian women in New York City. J Immigr Minor Health 8(3):211–221PubMedCrossRef

17.

Kagawa-Singer M, Pourat N (2000) Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives. Cancer 89(3):696–705PubMedCrossRef

18.

McPhee SJ, Stewart S, Brock KC, Bird JA, Jenkins CN, Pham GQ (1997) Factors associated with breast and cervical cancer screening practices among Vietnamese American women. Cancer Detect Prev 21(6):510–521PubMed

19.

Sadler GR, LaHousse SF, Riley J, Mercado B, Trinh AC, Cruz LAC (2010) Predictors of breast and cervical cancer screening among Chamorro women in Southern California. J Cancer Educ 25(1):76–82PubMedCrossRef

20.

Pasick RJ, Barker JC, Otero-Sabogal R, Burke NJ, Joseph G, Guerra C (2009) Intention, subjective norms and cancer screening in the context of relational culture. Health Education & Behavior 36(5):91S–110S

21.

Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N (2003) Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1):1182–1187PubMed

22.

Rosario AM (2010) Meeting Chamorro women's health care needs: examining the cultural impact of mamahlao on gynaecological screening. Pac Health Dialog 16(1):81–90PubMed

Title: What Promotes Cervical Cancer Screening Among Chamorro Women in California?
Authors: Sora P. Tanjasiri
Michele Mouttapa
Lola Sablan-Santos
Lourdes F. Quitugua
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 4/2012
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-012-0394-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Breast Cancer Knowledge, Attitudes and Screening Behaviors in Two Groups of Iranian Women: Physicians and Non-health Care Personnel

The Mayo Clinic Breast Cancer Book: A New Resource for Patients Navigating Breast Cancer

Colorectal Cancer Screening Practices in Alabama: A Survey of Primary Care Physicians

Health Care Providers’ Perspectives of an Intervention Designed to Improve Colorectal Cancer Screening Rates in Family Medicine Residency Clinics

Developing an Interactive Web-Based Learning Program on Skin Cancer: the Learning Experiences of Clinical Educators

Second-Year Italian Medical Students' Attitudes toward Care of the Dying Patient: an Exploratory Study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer